Peddling pills: the rise of direct-to-consumer prescription drug advertising and the dangers to consumers.(Commercialism Run Amok)(Cover Story): An article from: Multinational Monitor
Book Details
Author(s)Larry Sasich
PublisherEssential Information, Inc.
ISBN / ASINB00098QPCU
ISBN-13978B00098QPC7
AvailabilityAvailable for download now
Sales Rank11,940,957
MarketplaceUnited States 🇺🇸
Description
This digital document is an article from Multinational Monitor, published by Essential Information, Inc. on January 1, 1999. The length of the article is 2523 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the supplier: The growing use of direct-to-consumer (DTC) advertising by pharmaceutical firms poses dangers to consumers. This is because the Food and Drug Administration has no clear regulations that directly address the problems inherent in DTC advertising. DTC advertising expenditures by drug companies increased from $25 million in 1988 to over $225 million in 1994. In 1996, the total reached $610 million and in 1998 it rose to more than $1 billion. While supporters of DTC prescription advertising claim its purpose is to educate the consumers, critics argue that DTC advertisements are often misleading.
Citation Details
Title: Peddling pills: the rise of direct-to-consumer prescription drug advertising and the dangers to consumers.(Commercialism Run Amok)(Cover Story)
Author: Larry Sasich
Publication:Multinational Monitor (Refereed)
Date: January 1, 1999
Publisher: Essential Information, Inc.
Volume: 20 Issue: 1-2 Page: 23(5)
Article Type: Cover Story
Distributed by Thomson Gale
From the supplier: The growing use of direct-to-consumer (DTC) advertising by pharmaceutical firms poses dangers to consumers. This is because the Food and Drug Administration has no clear regulations that directly address the problems inherent in DTC advertising. DTC advertising expenditures by drug companies increased from $25 million in 1988 to over $225 million in 1994. In 1996, the total reached $610 million and in 1998 it rose to more than $1 billion. While supporters of DTC prescription advertising claim its purpose is to educate the consumers, critics argue that DTC advertisements are often misleading.
Citation Details
Title: Peddling pills: the rise of direct-to-consumer prescription drug advertising and the dangers to consumers.(Commercialism Run Amok)(Cover Story)
Author: Larry Sasich
Publication:Multinational Monitor (Refereed)
Date: January 1, 1999
Publisher: Essential Information, Inc.
Volume: 20 Issue: 1-2 Page: 23(5)
Article Type: Cover Story
Distributed by Thomson Gale
